In last trading session, Larimar Therapeutics Inc (NASDAQ:LRMR) saw 0.48 million shares changing hands with its beta currently measuring 0.99. Company’s recent per share price level of $6.57 trading at $0.24 or 3.79% at ring of the bell on the day assigns it a market valuation of $419.23M. That closing price of LRMR’s stock is at a discount of -108.22% from its 52-week high price of $13.68 and is indicating a premium of 66.82% from its 52-week low price of $2.18. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.95 million shares which gives us an average trading volume of 574.30K if we extend that period to 3-months.

For Larimar Therapeutics Inc (LRMR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.12. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.38 in the current quarter.

Larimar Therapeutics Inc (NASDAQ:LRMR) trade information

Upright in the green during last session for gaining 3.79%, in the last five days LRMR remained trading in the red while hitting it’s week-highest on Monday, 09/23/24 when the stock touched $6.57 price level, adding 7.59% to its value on the day. Larimar Therapeutics Inc’s shares saw a change of 44.40% in year-to-date performance and have moved -7.07% in past 5-day. Larimar Therapeutics Inc (NASDAQ:LRMR) showed a performance of -17.57% in past 30-days. Number of shares sold short was 3.33 million shares which calculate 8.41 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 14.5 to the stock, which implies a rise of 54.69% to its current value. Analysts have been projecting 4 as a low price target for the stock while placing it at a high target of 25. It follows that stock’s current price would jump 39.12% in reaching the projected high whereas dropping to the targeted low would mean a gain of 39.12% for stock’s current value.

Larimar Therapeutics Inc (LRMR) estimates and forecasts

Statistics highlight that Larimar Therapeutics Inc is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -13.44% of value to its shares in past 6 months, showing an annual growth rate of -66.67% while that of industry is 20.50. Apart from that, the company came lowering its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 48.33% during past 5 years.

Larimar Therapeutics Inc (NASDAQ:LRMR)’s Major holders

Insiders are in possession of 1.45% of company’s total shares while institution are holding 108.07 percent of that, with stock having share float percentage of 109.66%. Investors also watch the number of corporate investors in a company very closely, which is 108.07% institutions for Larimar Therapeutics Inc that are currently holding shares of the company. DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is the top institutional holder at LRMR for having 21.23 million shares of worth $153.93 million. And as of 2024-06-30, it was holding 39.6461 of the company’s outstanding shares.

The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 6.05 million shares on 2024-06-30. The number of shares represents firm’s hold over 11.2884 of outstanding shares, having a total worth of $43.83 million.